The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or “the Company”) (NYSE: CRL) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Charles River disclosed on February 22, 2023, that it had received a DOJ subpoena regarding an investigation of its allegedly illegal transport of primates for research purposes. The Company admitted it would voluntarily stop importing primates from Cambodia. The Company also warned that the investigations and its suspension of imports would negatively impact its business. Based on this news, shares of Charles River fell by as much as 15% in intraday trading on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at email@example.com.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223005367/en/
The Schall Law Firm
Brian Schall, Esq.